Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Themis and Merck announced the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire privately-held Themis.
read more
Apotex is voluntarily recalling all lots of Metformin Hydrochloride Extended-Release Tablets, USP 500mg within expiry to retail level.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
HemaCare has expanded its portfolio of GMP-compliant cellular material with the launch of the GMPrime cryopreserved leukopak.
read more
The companies are coming together to form a coalition to accomplish their shared goal of bringing promising cancer therapies to patients.
read more
Octapharma and BioMatrix Specialty Pharmacy are supporting a new study focused on treating patients with COVID-19 and presenting with COVID-19-associated myocardial dysfunction.
read more
Orbita has secured $9 million of venture funding as part of the company's Series A financing round.
read more
I-MED Pharma is collaborating with KMG International Limited to manufacture and supply PPE and COVID-19 diagnostic tests.
read more
Almac Group has received a $288,000 grant to support a clinical study in Sub-Saharan Africa in efforts to find a treatment for Coronavirus.
read more
Lonza Sanquin Reagents have entered into a strategic partnership for the commercialization of a range of specialized reagents for pyrogen testing of parenteral pharmaceuticals and medical devices using the Monocyte Activation Test.
read more
Ajinomoto Bio-Pharma Services has completed the acquisition of Granules OmniChem Private, purchasing the remaining 50 percent ownership interest from Granules India.
read more
Centinel Spine® announced FDA approval for the manufacturing transfer of both the prodisc® C Cervical Total Disc Replacement and prodisc® L Lumbar Total Disc Replacement systems to new vendors.
read more
Rentschler Biopharma has entered into a collaboration with Genmab for the development and manufacture of bispecific antibodies generated with Genmab’s DuoBody technology platform.
read more
Oncodesign has formed a new strategic alliance with HitGen, a Chinese biotech company.
read more
CordenPharma announced the signing of an amendment to their existing manufacturing agreement with Moderna, a clinical stage biotechnology company.
read more